En la esclerosis sistémica, el esófago se afecta en un 90%, seguido de los tramos anorrectal (%), gástrico ( 70%), colon (%) e intestino delgado. La esclerodermia es un relativamente infrecuente enfermedad reumática autoinmunitaria que afecta la piel y otros órganos del cuerpo. La esclerosis sistémica es una enfermedad autoinmune del tejido conectivo, que se caracteriza por un depósito excesivo de tejido colágeno y otros.

Author: Nashura Dikazahn
Country: Netherlands
Language: English (Spanish)
Genre: Relationship
Published (Last): 11 December 2008
Pages: 179
PDF File Size: 16.65 Mb
ePub File Size: 18.91 Mb
ISBN: 926-6-38679-352-8
Downloads: 70031
Price: Free* [*Free Regsitration Required]
Uploader: Nit

Nailfold capillaroscopy in the screening and diagnosis of Raynaud’s phenomenon.

There was a problem providing the content you requested

The immunosupressor therapy with cyclophosphamide and the transplant of hematopoietic cells, may be beneficial. Comparable effects of sildenafil citrate and alprostadil on severe Raynaud’s phenomenon in a patient with systemic sclerosis.

Rheum Dis Clin North Am, 22pp. N Engl J Med,pp. Objective benefit of nifedipine in the treatment of Raynaud’s phenomenon: Circulation, 53pp. Disturbed right ventricular diastolic function in patients with systemic sclerosis: Br J Clin Pharmacol, esclerosiispp.


Treatment of severe Raynaud’s phenomenon in collagen diseases with alprostadil IV. Curr Opin Rheumatol, 11pp. Surgical management of the hand in scleroderma.

JDDG, 5pp. Raynaud’s phenomenon as side effect of beta-blockers in hypertension. Bosentan therapy for pulmonary arterial hypertension. Noninvasive assessment of myocardial involvement in patients with systemic sclerosis: Sclerodermia can be localized or systemic, and the latter can compromise skin in a limited or diffuse type.

Circulation,pp. J Clin Pharmacol, 32pp. These lesions are extremely painful, heal slowly and lead to substantial functional disability.

Ulcere digitali in una coorte di pazienti sclerodermici. Am J Med, 61pp. J Rheumatol, 32pp.

Tratamiento de la esclerosis sistémica | Reumatología Clínica

Cyclosporine in systemic sclerosis. Rheumatology, 45pp. Ann Rheum Dis, 62pp. Endothelin and endothelin receptor antagonists in systemic rheumatic disease. Treprostinil for the treatment esvlerosis severe digital necrosis in systemic sclerosis. Systemic sclerosis therapy with iloprost: Prevention by treatment with bosentan, an oral endothelin receptor antagonist.

Successful treatment of severe Raynaud’s phenomenon with bosentan in four patients with systemic sclerosis. Am J Med, 87pp.


Are you a health professional able to prescribe or dispense drugs? Curr Opin Rheumatol, 17pp.

Increased whole blood platelet aggregation in patients with Raynaud’s phenomenon ssistemica or without systemic sclerosis. The relationship of arrhytmias and conduction disturbances to other manifestations of cardiopulmonary disease in progressive systemic sclerosis PSS. The influence of different beta-blocking drugs on the peripheral circulation in Raynaud phenomenon and in hypertension.

Medicine Baltimore50pp. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders.